American Renal Associates Holdings, Inc. (NYSE:ARA) is among the top losers of the stock market today, sinking -4.03% or (-0.26 points) to $6.19 from its previous close of $6.45. Does this decline mean it the best stock to buy right now? The shares seem to have an active trading volume day with a reported 166837 contracts so far this session. ARA shares had a relatively better volume day versus average trading capacity of 263.98 thousand shares, but with a 30.73 million float and a -5.29% run over a week, it’s definitely worth keeping an eye on. The one year price forecast for ARA stock indicates that the average analyst price target is $8.6 per share. This means the stock has a potential increase of 38.93% from where the ARA share price has been trading recently which is between $6.43 and $6.85. There are some brokerage firms that offer lower targets than the average, with one of them, even setting their price target at $7.
The most recent news story about the stock that appeared in Yahoo Finance‘s news section was titled “Edited Transcript of ARA earnings conference call or presentation 20-May-19 8:30pm GMT” and dated June 10, 2019.
During the recent trading session for American Renal Associates Holdings, Inc. (NYSE:ARA), the company witnessed their stock drop by $-0.31 over a week and tumble down $-0.21 from the price 20 days ago. When compared to their established 52-week high of $23.99, the high they recorded in their recent session happens to be lower. Their established 52-week high was attained by the company on 08/23/18. The recent low of $5.48 stood for a -74.2% since 04/17/19, a data which is good for most investors who are looking to take advantage of the stock’s recent rise. A beta of 0 is also allocated to the stock. Since the beta is less than one, it implies that the stock is more volatile than the market, a data that traders are keeping close attention to.
Looking at the current readings for American Renal Associates Holdings, Inc., the two-week RSI stands at 42.98. This figure suggests that ARA stock, for now, is neutral, meaning that the shares are stable in terms of price movement. The stochastic readings, on the other hand, based on the current ARA readings is similarly very revealing as it has a stochastic reading of 51.26% at this stage. This figure means that ARA share price today is being neutral.
Technical chart claims that American Renal Associates Holdings, Inc. (ARA) would settle between $6.72/share to $7/share level. However, if the stock price goes below the $6.3 mark, then the market for American Renal Associates Holdings, Inc. becomes much weaker. If that happens, the stock price might even plunge as low as $6.16 for its downside target. The stock is currently in the red zone of MACD, with the indicator reading -0.1. Traders are always alerted for the move of a stock above or below the zero line due to the fact that the reading is an indicator of the position of the short-term average relative to the long-term average. If the MACD is above the zero line, then the short-term average relative is above that of the long-term average, thus implying an upward momentum. Vice versa is the case if the MACD is below the zero line.
Analysts at SunTrust lowered their recommendation on shares of ARA from Buy to Hold in their opinion released on March 11. Deutsche Bank, analysts launched coverage of American Renal Associates Holdings, Inc. (NYSE:ARA) stock with a Hold recommendation, according to their flash note issued to investors on January 03. Analysts at Morgan Stanley, made their first call for the equity with a Equal-Weight recommendation, according to a research note that dated back to December 14.
ARA equity has an average rating of 3, with the figure leaning towards a bullish end. 5 analysts who tracked the company were contacted by Reuters. Amongst them, 5 rated the stock as a hold while the remaining 0 were split even though not equally. Some analysts rate the stock as a buy or a strong buy while no rated it as a sell. 0 analysts rated American Renal Associates Holdings, Inc. (NYSE:ARA) as a buy or a strong buy while not a single analyst advised that investors should desist from purchasing the stock or sell them if they already own the company’s stock.
Moving on, ARA stock price is currently trading at 17.25X forward 12-month Consensus EPS estimates, and its P/S ratio is 0.26 while for the average stock in the same group, the multiple is 6.07.